Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study.

Correction to: Internal and Emergency Medicine (2018) 13:651–660 https://doi.org/10.1007/s11739-018-1835-9 In the original publication, one of the ARAPACIS collaborators Dr. “Leonardo Di Gennaro” name has been erroneously mentioned as “Leonardo De Gennaro”.

Synthesis of 3-alkyl-4-(cholomethyl)-1-RSO2-1-H-pyrrol-2-(5H)ones, using a sequential ATCR/[1,2] elimination, from 2,2-dichloro-N-(2-chloroallyl)-N-RSO2 amides